ASK TINA

U.S. Food and Drug Administration

Documents published by U.S. Food and Drug Administration on weight-management medicines, compounding and peptide products. Every link goes to the regulator's own page. Informational only.

Ask Tina

Tina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.

At a glance

1Approvals and authorizations listed
9Guidance and safety documents listed

Good News

Positive coverage and opinions: this section collects regulator announcements of approvals and authorizations.

FDA Approves First New Molecular Entity Under National Priority Voucher ProgramU.S. Food and Drug Administration · 2026-04-01

Balanced coverage

Primary documents from the regulator for your own interpretation. No third-party commentary or opinion pieces.

FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food and Drug Administration · 2026-10-01FDA to Telehealth Companies: What to Know When Promoting Compounded DrugsU.S. Food and Drug Administration · 2026-06-15Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C ActU.S. Food and Drug Administration · 2026-05-14FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks ListU.S. Food and Drug Administration · 2026-04-30FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) MedicationsU.S. Food and Drug Administration · 2026-04-03Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesityU.S. Food and Drug Administration · 2026-04-03Bulk Drug Substances Used in CompoundingU.S. Food and Drug Administration · 2026-03-26FDA Intends to Take Action Against Non-FDA-Approved GLP-1 DrugsU.S. Food and Drug Administration · 2026-02-06Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C ActU.S. Food and Drug Administration · 2025-01-07Ask Tina for links to further coverage

Tina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.

Go to the source

U.S. Food and Drug AdministrationRegulator website

Other regulators

Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.